CYTK News and Press, Cytokinetics Incorporated From 02/19/26

2026-02-19 11:28:56 ET Bristol-Myers Squibb Company ( BMY ) shares have risen 27.7% since my last article , " Why Bristol-Myers Squibb Remains Undervalued In 2025," in mid-November. They have outperformed the S&P 500 [3.6% return] ( SPY ) during that time.... R...

European Commission Approval Based on Results of SEQUOIA-HCM First European Launch Expected in Germany in Q2 2026 SOUTH SAN FRANCISCO, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the European Commission (EC) has approved MYQORZO&...

SOUTH SAN FRANCISCO, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is scheduled to report fourth quarter results on February 24, 2026 at 4:00 PM Eastern Time. Following the announcement, Cytokinetics’ senior management will host...

Grants Awarded to Two Patient Advocacy Organizations  to Support Communications and Community Outreach SOUTH SAN FRANCISCO, Calif., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the recipients of its eighth annual Communications Grant Progra...

“On Track with HCM” Features Practical Insights for Managing Everyday Life with the Disease, Inspired by the Experience with HCM of McLaughlin-Levrone’s Father, Willie McLaughlin SOUTH SAN FRANCISCO, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (...

MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying  Hypercontractility Associated with Obstructive HCM SOUTH SAN FRANCISCO, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that MYQORZO™ ( aficamten) is now avail...

The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Cytokinetics, Incorporated (“Cytokinetics” or the “Company”) (NASDAQ: CYTK ) concerning whether the board breached its fiduciary duties to shareholders. If yo...

2026-01-12 15:46:00 ET Cytokinetics, Incorporated (CYTK) 44th Annual J.P. Morgan Healthcare Conference January 12, 2026 12:45 PM EST... Read the full article on Seeking Alpha For further details see: Cytokinetics, Incorporated (CYTK) Presents at 44th Annual J.P. Morgan Healt...

SOUTH SAN FRANCISCO, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to present at the 44 th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 9:45 A...

2025-12-22 17:33:23 ET Overview Cytokinetics, Incorporated's ( CYTK ) stock is up over 40% since my last Buy rating in September.... Read the full article on Seeking Alpha For further details see: Cytokinetics: Small Label Differences With Big Commercial Stakes